Ancora Advisors’s Aethlon Medical AEMD Stock Holding History

Ancora Advisors’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-38	Closed	-$46K	–	1341
2020 Q1	$46K	Buy	+38	New	+$64.3K	﹤0.01%	898

Other funds holding AEMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CFN

Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ancora Advisors's AEMD Position: Q2 2020 in Review

Ancora Advisors sold out of Aethlon Medical (AEMD) in Q2 2020, closing a stake of 38 shares — an estimated $46K sold.

Ancora Advisors first reported a position in AEMD in Q1 2020 and held it in 1 quarter. The position peaked at $46K in Q1 2020. 13 funds tracked by Wall St. Rank hold AEMD as of Q2 2020.

Ancora Advisors reported no remaining Aethlon Medical position as of Q2 2020 after selling out during the quarter.
Ancora Advisors sold 38 Aethlon Medical shares in Q2 2020, an estimated $46K.
Ancora Advisors first reported a position in Aethlon Medical in Q1 2020 and held it in 1 quarter.
Ancora Advisors's Aethlon Medical position peaked at $46K in Q1 2020.
13 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2020.

Based on Ancora Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.